Finnish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Acta Medica Croatica 2009-Oct

[Lysosomes and apoptosis].

Vain rekisteröityneet käyttäjät voivat kääntää artikkeleita
Kirjaudu sisään Rekisteröidy
Linkki tallennetaan leikepöydälle
Drazen Vikić-Topić
Olga Carević

Avainsanat

Abstrakti

In 1955, Christian de Duve and his coworkers from the School of Medicine in Louvain, Belgium, named a group of cytoplasmic formations surrounded by lipoprotein membrane and containing acid hydrolase enzymes as lysosomes. Biochemical and cytochemical studies showed lysosomes to be found in animal and vegetable eukaryotic cells. Later on, lysosomes were found to be involved in the dynamics of lysosomal system, which consists of a number of various cytoplasmic formations such as primary and secondary lysosomes, endosomes, autophagosomes and postlysosomes. These formations are inter-connected by the mechanism of membrane integration, and in some instances by the cell membrane. Lysosomal system is involved in numerous physiological processes such as degradation of endogenous and exogenous macromolecules (proteins, lipids, polysaccharides and nucleic acids), cytoplasmic formations (mitochondria, peroxisomes, Golgi complex) that have performed their functions, tissue regression (post-lactation mammary gland), hormone secretion regulation (proinsulin to insulin), etc. On the other hand, lysosomal system is also involved in a number of pathologic processes like inflammation, allergic reactions, ischemia, hypoxia, as well as in lysosomal diseases (thesaurismoses), e.g., type II glycogenosis, fucosidosis, mucolipidosis III, etc. In 1974, Christian de Duve introduced the term lysosomotropism, denoting entry of the pharmacologically active, toxic and carcinogenic substances in the lysosomal system irrespective of their chemical nature and mechanism of input. Lysosomotropic substances may act in two ways: (1) causing impairments in the intralysosomal area, with toxic manifestations; and (2) modifying their membrane properties by increasing or decreasing membrane permeability, or by inducing labilizing or stabilizing effects. Damage to the lysosomal system occurs in the late stage of necrosis, while destabilization of lysosomal formations has been recorded in primary processes during apoptosis.

Liity facebook-sivullemme

Täydellisin lääketieteellinen tietokanta tieteen tukemana

  • Toimii 55 kielellä
  • Yrttilääkkeet tieteen tukemana
  • Yrttien tunnistaminen kuvan perusteella
  • Interaktiivinen GPS-kartta - merkitse yrtit sijaintiin (tulossa pian)
  • Lue hakuusi liittyviä tieteellisiä julkaisuja
  • Hae lääkekasveja niiden vaikutusten perusteella
  • Järjestä kiinnostuksesi ja pysy ajan tasalla uutisista, kliinisistä tutkimuksista ja patenteista

Kirjoita oire tai sairaus ja lue yrtteistä, jotka saattavat auttaa, kirjoita yrtti ja näe taudit ja oireet, joita vastaan sitä käytetään.
* Kaikki tiedot perustuvat julkaistuun tieteelliseen tutkimukseen

Google Play badgeApp Store badge